[{"address1": "150 West 4th Ave", "city": "Vancouver", "state": "BC", "zip": "V5Y 1G6", "country": "Canada", "phone": "604 559 9005", "website": "https://www.abcellera.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.", "fullTimeEmployees": 596, "companyOfficers": [{"maxAge": 1, "name": "Dr. Carl L.G. Hansen Ph.D.", "age": 49, "title": "CEO, President & Chairperson", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 746836, "exercisedValue": 210706, "unexercisedValue": 2408685}, {"maxAge": 1, "name": "Mr. Andrew  Booth M.B.A.", "age": 50, "title": "Chief Financial Officer", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 671720, "exercisedValue": 0, "unexercisedValue": 12299500}, {"maxAge": 1, "name": "Dr. Veronique  Lecault Ph.D.", "age": 39, "title": "CTO & Director", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 667706, "exercisedValue": 230210, "unexercisedValue": 1260000}, {"maxAge": 1, "name": "Mr. Tryn T. Stimart Esq., J.D., M.Sc.", "age": 54, "title": "Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 685080, "exercisedValue": 0, "unexercisedValue": 3502170}, {"maxAge": 1, "name": "Marcie  Thiessen CPA, CGA", "title": "Senior Director of Finance & Accounting", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Tiffany  Chiu B.Sc., Ph.D.", "title": "Vice President of Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Graham  Craig M.Sc.", "title": "Director of Corporate Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Murray  McCutcheon Ph.D.", "title": "Senior Vice President of Partnering", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Neil  Aubuchon B.A., M.B.A.", "age": 54, "title": "Chief Commercial Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 684813, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Adam  Clarke M.A.I.C.D., Ph.D.", "title": "Senior Vice President of Discovery", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 9, "compensationRisk": 8, "shareHolderRightsRisk": 5, "overallRisk": 7, "governanceEpochDate": 1756684800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.16, "open": 4.23, "dayLow": 4.09, "dayHigh": 4.28, "regularMarketPreviousClose": 4.16, "regularMarketOpen": 4.23, "regularMarketDayLow": 4.09, "regularMarketDayHigh": 4.28, "payoutRatio": 0.0, "beta": 0.645, "forwardPE": -6.393939, "volume": 4154868, "regularMarketVolume": 4154868, "averageVolume": 6550158, "averageVolume10days": 3753250, "averageDailyVolume10Day": 3753250, "bid": 4.21, "ask": 5.29, "bidSize": 1, "askSize": 2, "marketCap": 1261075200, "fiftyTwoWeekLow": 1.891, "fiftyTwoWeekHigh": 5.82, "priceToSalesTrailing12Months": 38.358536, "fiftyDayAverage": 4.2868, "twoHundredDayAverage": 3.093925, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 850076864, "profitMargins": 0.0, "floatShares": 202749166, "sharesOutstanding": 298832992, "sharesShort": 41784407, "sharesShortPriorMonth": 35716688, "sharesShortPreviousMonthDate": 1752537600, "dateShortInterest": 1755216000, "sharesPercentSharesOut": 0.1398, "heldPercentInsiders": 0.22941999, "heldPercentInstitutions": 0.3848, "shortRatio": 6.25, "shortPercentOfFloat": 0.1815, "impliedSharesOutstanding": 298832992, "bookValue": 3.405, "priceToBook": 1.2393539, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -165664992, "trailingEps": -0.56, "forwardEps": -0.66, "enterpriseToRevenue": 25.857, "enterpriseToEbitda": -3.893, "52WeekChange": 0.7583333, "SandP52WeekChange": 0.18469036, "quoteType": "EQUITY", "currentPrice": 4.22, "targetHighPrice": 17.0, "targetLowPrice": 5.0, "targetMeanPrice": 9.33333, "targetMedianPrice": 8.5, "recommendationMean": 1.375, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 553078016, "totalCashPerShare": 1.851, "ebitda": -218379008, "totalDebt": 142080000, "quickRatio": 9.496, "currentRatio": 11.073, "totalRevenue": 32876000, "debtToEquity": 14.108, "revenuePerShare": 0.111, "returnOnAssets": -0.10955, "returnOnEquity": -0.15642999, "grossProfits": -135880000, "freeCashflow": -207588000, "operatingCashflow": -80840000, "revenueGrowth": 1.333, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -2.90242, "financialCurrency": "USD", "symbol": "ABCL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketTime": 1757116714, "regularMarketTime": 1757102401, "market": "us_market", "esgPopulated": false, "shortName": "AbCellera Biologics Inc.", "longName": "AbCellera Biologics Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1607697000000, "postMarketChangePercent": -0.234588, "postMarketPrice": 4.2101, "postMarketChange": -0.00989962, "regularMarketChange": 0.0599999, "regularMarketDayRange": "4.09 - 4.28", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 6550158, "fiftyTwoWeekLowChange": 2.3289998, "fiftyTwoWeekLowChangePercent": 1.2316233, "fiftyTwoWeekRange": "1.891 - 5.82", "fiftyTwoWeekHighChange": -1.6000004, "fiftyTwoWeekHighChangePercent": -0.27491415, "fiftyTwoWeekChangePercent": 75.833336, "earningsTimestamp": 1754596800, "earningsTimestampStart": 1762200000, "earningsTimestampEnd": 1762200000, "earningsCallTimestampStart": 1754600400, "earningsCallTimestampEnd": 1754600400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.56, "epsForward": -0.66, "epsCurrentYear": -0.58667, "priceEpsCurrentYear": -7.193141, "fiftyDayAverageChange": -0.06680012, "fiftyDayAverageChangePercent": -0.015582747, "twoHundredDayAverageChange": 1.1260748, "twoHundredDayAverageChangePercent": 0.3639632, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "corporateActions": [], "exchange": "NMS", "messageBoardId": "finmb_280568380", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "ipoExpectedDate": "2020-12-11", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "regularMarketChangePercent": 1.44231, "regularMarketPrice": 4.22, "marketState": "CLOSED", "displayName": "AbCellera Biologics", "trailingPegRatio": null, "__fetch_time": "2025-09-06"}]